Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › SLDB

SILVERARC CAPITAL MANAGEMENT, LLC position in SLDB

SOLID BIOSCIENCES INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 760,337 shares of SLDB (SOLID BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$5.5M, representing 0.70% of its reported portfolio and ranking #38 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed SLDB holdings in 7 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)760.34K sh
Reported value held$5.50M
Portfolio Weight0.70%
First reportedQ4 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's SLDB position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in SLDB in Q4 2023 at 594,855 shares (US$3.7M). The position peaked in Q1 2024 at 1,325,065 shares, worth US$17.6M. Across 7 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 760,337 shares valued at US$5.5M — an increase of 91,887 shares quarter over quarter.. Notable position changes include a 123% increase in Q1 2024 (shares fell 57% over the following quarter), a 64% trim in Q2 2024 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 594.86K $3.65M New
Q1 2024 1.33M $17.65M Add
Q2 2024 473.00K $2.68M Reduce
Q3 2024 457.74K $3.19M Reduce
Q1 2025 452.24K $1.67M New
Q2 2026 668.45K $6.68M New
Q3 2026 760.34K $5.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLDB and 13F data

SLDB (SOLID BIOSCIENCES INC) is a Health Care company. 45 other funds we track also report a position in SLDB — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$120.2M), PERCEPTIVE ADVISORS LLC (US$118.9M), Bain Capital Life Sciences Investors, LLC (US$98.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLDB

All SLDB fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held SLDB?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed SLDB holdings in 7 of the last 12 reported quarters, going back to Q4 2023.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in SLDB?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 760.34K shares of SLDB (SOLID BIOSCIENCES INC), valued at $5.50M, representing 0.70% of its reported portfolio and ranking #38.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling SLDB?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in SLDB. The position peaked in Q1 2024 at 1.33M shares.

Which other funds hold SLDB?

Other major institutional holders of SLDB include RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.